Announced Tue, 11 Aug · 12:52 IST
Newspaper publication of Q1 FY27 unaudited financial results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.1%1-day move
₹2.91
prior close
₹2.97
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+2.1+2.4-5.8+3.8-2.1-4.8-1.4-4.8——
Up moveDown movePending
AI summary
Transgene Biotek filed newspaper clippings of unaudited Q1 FY27 results (quarter ended June 30, 2026) under SEBI Regulation 47. Total income was Rs 6.00 lakhs vs Rs 4.95 lakhs in Q1 FY26. Net loss after tax narrowed to Rs 38.90 lakhs from Rs 43.37 lakhs. EPS stood at minus 0.05. Published in Business Standard and Navatelangana.
Likely market impact
Routine compliance filing; small revenue uptick and modestly lower losses versus year ago quarter. Limited material impact for shareholders.